Danielle Kellar

Statistics

Publications

Citations

457

H-Index

Active since

2013

Affiliations

University of California, San Francisco(Current)

University of California San Diego

University of Montana

Center for Discovery

Fundação Oswaldo Cruz

Danielle Kellar is an author at University of California, San Francisco specializing in trypanosoma cruzi infection, drug discovery, and pharmacology.

Publications per year

2013–2015

Publications

Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase

Laura‐Isobel McCall, Amale El Aroussi, Jun Yong Choi et al. · PLoS neglected tropical diseases · 2015 · 122 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery

Sean Ekins, Jair L. Siqueira-Neto, Laura‐Isobel McCall et al. · PLoS neglected tropical diseases · 2015 · 96 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17

Synthesis of a Sugar-Based Thiosemicarbazone Series and Structure-Activity Relationship versus the Parasite Cysteine Proteases Rhodesain, Cruzain, and Schistosoma mansoni Cathepsin B1

Nayara Cristina Fonseca, Luana Faria da Cruz, Filipe da Silva Villela et al. · Antimicrobial Agents and Chemotherapy · 2015 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-<i>Trypanosoma cruzi</i>Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency

Cláudia M. Calvet, Débora Vieira, Jun Yong Choi et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Diversity-Oriented Synthesis Yields a New Drug Lead for Treatment of Chagas Disease

Sivaraman Dandapani, Andrew Germain, Ivan T. Jewett et al. · ACS Medicinal Chemistry Letters · 2013 · 42 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

1–5 of 8